Interstitial Lung Disease

Interstitial Lung Disease Treatment

Interstitial lung disease treatment

Interstitial Lung Disease Treatment Available at the Lung Institute

Treatment for interstitial lung disease is available at the Lung Institute, the only stem cell therapy center in the world focusing exclusively on lung disease. We offer stem cell treatment options that are designed to potentially address the progression of this disease and help improve quality of life for patients living with a severe pulmonary condition.

Stem cells have the remarkable power to aid in healing, as they can regenerate and transform themselves to function as different types of tissue. The Lung Institute offers two types of autologous stem cell therapy: bone marrow therapy, where the stem cells are extracted from the patient’s bone marrow, and venous therapy, where stem cells are taken from the patient’s blood. Both procedures are minimally invasive and are performed on an outpatient basis over the course of two days.

We use the following three-step process when performing natural stem cell therapy:

  • Harvest – We remove a small sample of the patient’s blood or bone marrow, depending on the type of stem cell procedure being performed.
  • Separate – We separate the stem cells from the remaining cells in the patient’s sample in our in-house lab.
  • Return – We intravenously return the concentrated stem cells into the patient’s bloodstream.

Although current treatments cannot reverse existing damage caused by the condition or cure lung disease, stem cell treatment may slow the progression of lung disease. Many people coping with interstitial lung disease who have undergone stem cell therapy at the Lung Institute have shown enhanced lung function and experienced improvement in their quality of life.

If you’re interested in learning more about the Lung Institute’s alternative interstitial lung disease treatment options, please call us today at (800) 729-3065. One of our devoted team members can answer any questions you may have and provide you with additional information. We look forward to helping you breathe easier.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.